Home Latest news Decentralized clinical trials and rare diseases

Decentralized clinical trials and rare diseases

by informer

Traditional clinical trials require tests and procedures that are administered in centralized clinical research sites, which are beyond the standard of care that patients receive for their rare and chronic diseases. The limited number of rare disease patients scattered around the world makes it particularly challenging to recruit participants and conduct these traditional clinical trials.

Participating in clinical research can be burdensome, especially for children, the elderly, physically and cognitively impaired individuals who require transportation and caregiver assistance, or patients who live in remote locations or cannot afford transportation. In recent years, there is an increasing need to consider Decentralized Clinical Trials as a participant-centric approach that uses new technologies and innovative procedures for interaction with participants in the comfort of their home.

This report discusses the planning and conduct of Decentralized Clinical Trials, which can increase the quality of trials with a specific focus on rare diseases. Read the full article here.

Related Articles